MCID: SCH012
MIFTS: 54

Schizoaffective Disorder

Categories: Mental diseases

Aliases & Classifications for Schizoaffective Disorder

MalaCards integrated aliases for Schizoaffective Disorder:

Name: Schizoaffective Disorder 12 76 25 55 15 73
Schizophreniform Psychosis, Affective Type 25
Schizophrenia, Schizo-Affective Type 25
Schizo-Affective Type Schizophrenia 25
Schizoaffective Schizophrenia 25
Schizo-Affective Psychosis 25
Schizoaffective Psychosis 25

Classifications:



External Ids:

Disease Ontology 12 DOID:5418
ICD10 33 F25 F25.9
ICD9CM 35 295.7
MeSH 44 D011618
NCIt 50 C94378
UMLS 73 C0036337

Summaries for Schizoaffective Disorder

Genetics Home Reference : 25 Schizoaffective disorder is a mental health condition that includes features of both schizophrenia and a mood disorder such as bipolar disorder or depression. The prefix "schizo-" refers to the psychotic symptoms of schizophrenia that affect a person's thinking, sense of self, and perceptions. The term "-affective" refers to extreme shifts in mood, energy, and behavior.

MalaCards based summary : Schizoaffective Disorder, also known as schizophreniform psychosis, affective type, is related to schizophreniform disorder and hyperprolinemia. An important gene associated with Schizoaffective Disorder is DISC2 (Disrupted In Schizophrenia 2
Specifically,the disruption of the DISC genomic locus,which encodes both the DISC1 protein-coding gene and the DISC2 lncRNA,has been linked in a number of genetic analyses to the risk of developing schizophrenia,schizoaffective disorder,bipolar disorder,major depression,and autistic spectrum disorders.
Dysfunction Pattern: ), and among its related pathways/superpathways are Neuroscience and Monoamine GPCRs. The drugs Fluspirilene and Chlorpromazine have been mentioned in the context of this disorder. Affiliated tissues include brain, testes and heart, and related phenotypes are behavior/neurological and homeostasis/metabolism

Disease Ontology : 12 A psychotic disorder that is characterized by recurring episodes of mood fluctuations and a loss of contact with reality.

Wikipedia : 76 Schizoaffective disorder (SZA, SZD or SAD) is a mental disorder characterized by abnormal thought... more...

Related Diseases for Schizoaffective Disorder

Diseases related to Schizoaffective Disorder via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 108, show less)
# Related Disease Score Top Affiliating Genes
1 schizophreniform disorder 30.8 COMT DRD2 PRL
2 hyperprolinemia 30.6 COMT PRODH
3 delusional disorder 30.4 DRD2 DRD3
4 tardive dyskinesia 30.1 COMT DRD2 DRD3 HTR2A
5 cocaine dependence 30.1 DRD2 DRD3 SLC6A4
6 anxiety 29.9 BDNF COMT HTR2A SLC6A4
7 schizotypal personality disorder 29.9 COMT SULT4A1
8 paranoid schizophrenia 29.7 BDNF COMT HTR2A SLC6A4
9 pathological gambling 29.7 DRD2 DRD3 HTR2A SLC6A4
10 borderline personality disorder 29.5 BDNF COMT HTR2A SLC6A4
11 depression 29.5 BDNF DISC2 HTR2A SLC6A4
12 bipolar i disorder 29.3 BDNF COMT DTNBP1 HTR2A SLC6A4
13 personality disorder 29.0 BDNF COMT DRD2 DRD3 HTR2A SLC6A4
14 substance abuse 28.8 BDNF COMT DRD2 DRD3 PRL SLC6A4
15 early-onset schizophrenia 28.6 BDNF COMT DRD2 DRD3 HTR2A SLC6A4
16 obsessive-compulsive disorder 28.2 BDNF COMT DRD2 DRD3 HTR2A PRL
17 alcohol dependence 27.7 BDNF COMT DRD2 DRD3 GABRB1 HTR2A
18 mood disorder 27.0 BDNF COMT DAOA DISC1 DISC2 DRD2
19 major depressive disorder 26.6 BDNF COMT DISC1 DISC2 DRD2 DRD3
20 bipolar disorder 25.7 BDNF COMT DAOA DISC1 DISC2 DRD2
21 psychotic disorder 25.4 BDNF COMT DAOA DISC1 DRD2 DRD3
22 schizophrenia 23.7 BDNF COMT DAOA DISC1 DISC2 DRD2
23 schizophrenia 4 10.8
24 schizophrenia 2 10.8
25 schizophrenia 9 10.8
26 schizophrenia 15 10.8
27 chromosome 2p16.3 deletion syndrome 10.8
28 schizophrenia 18 10.8
29 schizophrenia 19 10.8
30 schizophrenia 5 10.7 DRD3 HTR2A
31 galactorrhea 10.7 DRD2 PRL
32 obsessive-compulsive personality disorder 10.6 DRD3 SLC6A4
33 prolactin producing pituitary tumor 10.6 DRD2 PRL
34 alzheimer disease 5 10.5 HTR2A SLC6A4
35 polysubstance abuse 10.5 COMT DRD2 DRD3
36 impulse control disorder 10.5 DRD2 DRD3
37 mammographic density 10.5 COMT PRL
38 alcohol-induced mental disorder 10.5 DRD2 SLC6A4
39 social phobia 10.4 DRD2 PRL SLC6A4
40 opiate dependence 10.4 DRD2 DRD3 SLC6A4
41 psychosexual disorder 10.4 HTR2A SLC6A4
42 oppositional defiant disorder 10.3 COMT DRD2 SLC6A4
43 alexithymia 10.3 COMT DRD2 SLC6A4
44 cocaine abuse 10.3 DRD2 PRL SLC6A4
45 antisocial personality disorder 10.3 COMT DRD2 SLC6A4
46 phobic disorder 10.3 COMT SLC6A4
47 fibromyalgia 10.3 COMT HTR2A SLC6A4
48 traumatic brain injury 10.3 BDNF COMT DRD2
49 alcoholic psychosis 10.3 DRD2 HTR2A SLC6A4
50 periodic limb movement disorder 10.3 DRD2 HTR2A SLC6A4
51 conduct disorder 10.3 COMT DRD2 SLC6A4
52 brain injury 10.3 BDNF COMT DRD2
53 bruxism 10.3 DRD2 HTR2A SLC6A4
54 tobacco addiction 10.3 COMT DRD2 HTR2A
55 gilles de la tourette syndrome 10.2 BDNF COMT DRD2
56 specific developmental disorder 10.2 BDNF COMT SLC6A4
57 migraine without aura 10.2 DRD2 DRD3 PRL SLC6A4
58 dysthymic disorder 10.1 HTR2A SLC6A4
59 aging 10.1
60 premature ejaculation 10.1 COMT SLC6A4
61 postpartum depression 10.0 BDNF COMT PRL SLC6A4
62 drug dependence 10.0 BDNF DRD2 DRD3 SLC6A4
63 substance dependence 10.0 BDNF DRD2 DRD3 SLC6A4
64 multiple sclerosis 10.0
65 eating disorder 9.9 BDNF COMT DRD2 SLC6A4
66 mental depression 9.9 BDNF COMT HTR2A SLC6A4
67 bulimia nervosa 9.9 BDNF COMT HTR2A SLC6A4
68 schizophrenia 1 9.9
69 hepatitis 9.9
70 dementia 9.9
71 generalized anxiety disorder 9.9 BDNF DRD2 HTR2A SLC6A4
72 panic disorder 9.9 BDNF COMT HTR2A SLC6A4
73 heroin dependence 9.8 BDNF DRD2
74 alcohol abuse 9.7 BDNF DRD2 DRD3 PRL SLC6A4
75 arteries, anomalies of 9.7
76 cognitive function 1, social 9.7
77 major affective disorder 2 9.7
78 basal cell carcinoma 1 9.7
79 major affective disorder 4 9.7
80 major affective disorder 5 9.7
81 major affective disorder 6 9.7
82 major affective disorder 8 9.7
83 major affective disorder 7 9.7
84 major affective disorder 9 9.7
85 coronary artery anomaly 9.7
86 diabetes mellitus 9.7
87 hepatitis b 9.7
88 neutropenia 9.7
89 thrombocytopenia 9.7
90 porphyria 9.7
91 basal cell carcinoma 9.7
92 acute porphyria 9.7
93 cerebritis 9.7
94 myopathy 9.7
95 neuronitis 9.7
96 myocarditis 9.7
97 encephalopathy 9.7
98 headache 9.7
99 hypoxia 9.7
100 argyria 9.7
101 anorexia nervosa 9.7 BDNF COMT HTR2A PRL SLC6A4
102 post-traumatic stress disorder 9.6 BDNF COMT DRD2 HTR2A SLC6A4
103 attention deficit-hyperactivity disorder 9.3 BDNF COMT DRD2 DRD3 HTR2A SLC6A4
104 parkinson disease, late-onset 9.3 BDNF COMT DRD2 DRD3 HTR2A SLC6A4
105 migraine with or without aura 1 9.3 COMT DRD2 DRD3 HTR2A NOTCH4 SLC6A4
106 autism spectrum disorder 9.2 BDNF DISC2 HTR2A SLC6A4
107 autism 9.1 BDNF COMT DISC1 DRD2 DRD3 HTR2A
108 disease of mental health 8.5 BDNF COMT DISC1 DRD2 DRD3 DTNBP1

Graphical network of the top 20 diseases related to Schizoaffective Disorder:



Diseases related to Schizoaffective Disorder

Symptoms & Phenotypes for Schizoaffective Disorder

MGI Mouse Phenotypes related to Schizoaffective Disorder:

46 (showing 3, show less)
# Description MGI Source Accession Score Top Affiliating Genes
1 behavior/neurological MP:0005386 9.93 SLC6A4 BDNF COMT DISC1 DRD2 DRD3
2 homeostasis/metabolism MP:0005376 9.73 BDNF COMT DISC1 DRD2 DRD3 DTNBP1
3 nervous system MP:0003631 9.44 BDNF COMT DISC1 DRD2 DRD3 DTNBP1

Drugs & Therapeutics for Schizoaffective Disorder

Drugs for Schizoaffective Disorder (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 383, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Fluspirilene Approved, Investigational Phase 4 1841-19-6 3396
2
Chlorpromazine Approved, Investigational, Vet_approved Phase 4 50-53-3 2726
3
Simvastatin Approved Phase 4,Phase 3,Phase 2,Phase 1 79902-63-9 54454
4
Dopamine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 51-61-6, 62-31-7 681
5
Fluphenazine Approved Phase 4 69-23-8 3372
6
Minocycline Approved, Investigational Phase 4,Phase 3,Phase 1 10118-90-8 5281021
7
Clozapine Approved Phase 4,Phase 1,Not Applicable 5786-21-0 2818
8
Ziprasidone Approved Phase 4,Phase 2,Phase 3,Not Applicable 146939-27-7 60854
9
Modafinil Approved, Investigational Phase 4,Phase 2,Phase 1 68693-11-8 4236
10
Guanfacine Approved, Investigational Phase 4 29110-47-2 3519
11
Olanzapine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 132539-06-1 4585
12
Risperidone Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 106266-06-2 5073
13
Pimozide Approved Phase 4 2062-78-4 16362
14
Sulpiride Approved, Investigational Phase 4,Not Applicable 15676-16-1 5355
15
Aripiprazole Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 129722-12-9 60795
16 bromperidol Approved, Investigational Phase 4 10457-90-6 2448
17
Citalopram Approved Phase 4,Not Applicable 59729-33-8 2771
18 Benperidol Approved, Investigational Phase 4 2062-84-2
19
Perphenazine Approved Phase 4,Not Applicable 58-39-9 4748
20
Haloperidol Approved Phase 4,Phase 3,Not Applicable 52-86-8 3559
21
Donepezil Approved Phase 4 120014-06-4 3152
22
Ondansetron Approved Phase 4,Phase 2,Phase 1 99614-02-5 4595
23
Armodafinil Approved, Investigational Phase 4,Phase 2,Phase 1 112111-43-0
24 Perazine Approved, Investigational Phase 4 84-97-9
25
Zinc Approved, Investigational Phase 4 7440-66-6 23994
26
Exenatide Approved, Investigational Phase 4 141758-74-9 15991534
27
Nicotine Approved Phase 4,Phase 2,Phase 3,Not Applicable 54-11-5 942 89594
28
Metformin Approved Phase 4,Phase 3 657-24-9 14219 4091
29
Varenicline Approved, Investigational Phase 4,Phase 3,Phase 2 249296-44-4 5310966
30
Allopurinol Approved Phase 4 315-30-0 2094
31
Cocaine Approved, Illicit Phase 4,Phase 3 50-36-2 5760 446220
32
Acetylcholine Approved Phase 4,Phase 2 51-84-3 187
33
Galantamine Approved Phase 4,Phase 3,Phase 2 357-70-0 9651
34
Norepinephrine Approved Phase 4 51-41-2 439260
35
Miconazole Approved, Investigational, Vet_approved Phase 4,Not Applicable 22916-47-8 4189
36
Lorazepam Approved Phase 4,Phase 3,Phase 2 846-49-1 3958
37
Valproic Acid Approved, Investigational Phase 4,Phase 3,Phase 1 99-66-1 3121
38
Acamprosate Approved, Investigational Phase 4 77337-76-9 71158
39
Amphetamine Approved, Illicit, Investigational Phase 4,Phase 2 300-62-9 5826 3007
40
Bupropion Approved Phase 4 34841-39-9, 34911-55-2 444
41
Pravastatin Approved Phase 4 81093-37-0 54687
42
Pramlintide Approved, Investigational Phase 4 151126-32-8
43
Amantadine Approved Phase 4,Phase 3,Phase 1 768-94-5 2130
44
Ethanol Approved Phase 4,Phase 1,Phase 2,Not Applicable 64-17-5 702
45
Naltrexone Approved, Investigational, Vet_approved Phase 4,Not Applicable 16590-41-3 5360515
46
Telmisartan Approved, Investigational Phase 4 144701-48-4 65999
47
Acyclovir Approved Phase 4 59277-89-3 2022
48
Asenapine Approved Phase 4,Phase 3,Phase 2 85650-56-2, 65576-45-6 3001386
49
Angiotensin II Approved, Investigational Phase 4 68521-88-0, 4474-91-3, 11128-99-7 172198 65143
50
Molindone Approved Phase 4 7416-34-4 23897
51
Acetylcysteine Approved, Investigational Phase 4 616-91-1 12035
52
Cycloserine Approved Phase 4,Phase 2,Phase 3,Not Applicable 68-41-7 401 6234
53
Losartan Approved Phase 4 114798-26-4 3961
54
Prednisolone Approved, Vet_approved Phase 4 50-24-8 5755
55
Epinephrine Approved, Vet_approved Phase 4 51-43-4 5816
56
Methylprednisolone Approved, Vet_approved Phase 4 83-43-2 6741
57
Racepinephrine Approved Phase 4 329-65-7 838
58
Vitamin A Approved, Nutraceutical, Vet_approved Phase 4 11103-57-4, 68-26-8 445354
59
Choline Approved, Nutraceutical Phase 4,Phase 3,Phase 2 62-49-7 305
60
Melatonin Approved, Nutraceutical, Vet_approved Phase 4,Not Applicable 73-31-4 896
61
Glutamic Acid Approved, Nutraceutical Phase 4 56-86-0 33032
62
Betadex Experimental Phase 4 7585-39-9 320761
63 sultopride Phase 4,Not Applicable
64 Haloperidol decanoate Phase 4,Phase 3,Not Applicable
65 Quetiapine Fumarate Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 111974-72-2
66 Lithium carbonate Phase 4,Phase 2,Phase 1 554-13-2
67 Analgesics Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
68 Central Nervous System Depressants Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
69 Fluphenazine depot Phase 4
70 Fluphenazine enanthate Phase 4
71 Adrenergic Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
72 Central Nervous System Stimulants Phase 4,Phase 2,Phase 1,Not Applicable
73 Adrenergic Agonists Phase 4
74 Adrenergic alpha-2 Receptor Agonists Phase 4
75 Adrenergic alpha-Agonists Phase 4
76 Selective Estrogen Receptor Modulators Phase 4,Phase 3,Phase 2
77 Cholinergic Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
78 GABA Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
79 Serotonin 5-HT2 Receptor Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
80 Muscarinic Antagonists Phase 4,Not Applicable
81 Cholinergic Antagonists Phase 4,Not Applicable
82 Serotonin Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
83 Cholinesterase Inhibitors Phase 4,Phase 3,Phase 2
84 Serotonin Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
85 Serotonin Uptake Inhibitors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
86 Gastrointestinal Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
87 Clopenthixol Phase 4
88 Neurotransmitter Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
89 Cyclooxygenase Inhibitors Phase 4,Phase 3,Phase 2
90 Analgesics, Non-Narcotic Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
91 Neurotransmitter Uptake Inhibitors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
92 Cytochrome P-450 CYP3A Inducers Phase 4,Phase 2,Phase 1
93 N-Methylaspartate Phase 4,Phase 2,Not Applicable
94 Nootropic Agents Phase 4,Phase 3,Phase 2,Not Applicable
95 Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1
96 Dermatologic Agents Phase 4,Phase 2,Phase 1
97 Tranquilizing Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
98 Hormones Phase 4,Phase 3,Phase 2,Phase 1
99 Paliperidone Palmitate Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
100 Parasympatholytics Phase 4,Not Applicable
101 Anti-Anxiety Agents Phase 4,Phase 3,Phase 2,Phase 1
102 Dopamine Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
103 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1
104 Dopamine Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
105 Dopamine D2 Receptor Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
106 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
107 Hydroxymethylglutaryl-CoA Reductase Inhibitors Phase 4,Phase 3,Phase 2,Phase 1
108 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
109 Hypolipidemic Agents Phase 4,Phase 3,Phase 2,Phase 1
110 Estrogen Antagonists Phase 4,Phase 3,Phase 2
111 Estrogen Receptor Modulators Phase 4,Phase 3,Phase 2
112 Estrogens Phase 4,Phase 3,Phase 2
113 Antibodies Phase 4,Phase 1,Phase 2,Not Applicable
114 Immunoglobulins Phase 4,Phase 1,Phase 2,Not Applicable
115 Wakefulness-Promoting Agents Phase 4,Phase 2,Phase 1
116 Antihypertensive Agents Phase 4,Not Applicable
117 Anticholesteremic Agents Phase 4,Phase 3,Phase 2,Phase 1
118 Antidepressive Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
119 Antidepressive Agents, Second-Generation Phase 4,Not Applicable
120 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
121 Antiemetics Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
122 Antioxidants Phase 4,Phase 3,Phase 2,Not Applicable
123 Protective Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
124 Antiparkinson Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
125 Lipid Regulating Agents Phase 4,Phase 3,Phase 2,Phase 1
126 Anti-Inflammatory Agents Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
127 Antipruritics Phase 4,Phase 2,Phase 1
128 Antipsychotic Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
129 Psychotropic Drugs Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
130 Anti-Inflammatory Agents, Non-Steroidal Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
131 Raloxifene Hydrochloride Phase 4,Phase 3,Phase 2
132 Antimanic Agents Phase 4,Phase 2,Phase 1
133 Antirheumatic Agents Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
134 Antimetabolites Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
135 Autonomic Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
136 Bone Density Conservation Agents Phase 4,Phase 3,Phase 2,Not Applicable
137 valacyclovir Phase 4,Phase 2
138
Benztropine Phase 4,Not Applicable 86-13-5 6832
139 decanoic acid Phase 4,Phase 3,Not Applicable
140 insulin Phase 4,Phase 1,Phase 2,Not Applicable
141 Sodium salicylate Phase 4 54-21-7
142
Lurasidone hydrochloride Phase 4,Phase 3,Phase 2,Phase 1 367514-87-2 213046
143 Renal Agents Phase 4,Phase 2,Phase 3,Not Applicable
144 Respiratory System Agents Phase 4
145 Retinol palmitate Phase 4
146 S 20098 Phase 4
147 Salicylates Phase 4
148 Salicylsalicylic acid Phase 4
149 Adrenergic alpha-Antagonists Phase 4,Phase 3,Phase 2,Phase 1
150 Adrenergic Antagonists Phase 4,Phase 3,Phase 2,Phase 1
151 GABA Modulators Phase 4,Phase 3,Phase 2,Phase 1
152 Serotonin and Noradrenaline Reuptake Inhibitors Phase 4
153 Narcotic Antagonists Phase 4,Phase 2,Not Applicable
154 Narcotics Phase 4,Phase 2,Not Applicable
155 Neuroprotective Agents Phase 4,Phase 2,Phase 1,Not Applicable
156 Cytidine Diphosphate Choline Phase 4,Phase 3,Phase 2
157 Cytochrome P-450 CYP2D6 Inhibitors Phase 4
158 Cytochrome P-450 Enzyme Inhibitors Phase 4
159 Anesthetics Phase 4,Phase 3,Phase 2,Phase 1
160 Nicotinic Agonists Phase 4,Phase 3,Phase 2,Not Applicable
161 N-monoacetylcystine Phase 4
162 Anesthetics, Local Phase 4,Phase 3
163 Angiotensin II Type 1 Receptor Blockers Phase 4
164 Angiotensin Receptor Antagonists Phase 4
165 Angiotensinogen Phase 4
166 Vasoconstrictor Agents Phase 4,Phase 3,Phase 2
167 Anti-Arrhythmia Agents Phase 4,Phase 1
168 Dopamine Uptake Inhibitors Phase 4,Phase 3,Phase 2,Not Applicable
169 Duloxetine Hydrochloride Phase 4
170 Hypnotics and Sedatives Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
171 Hypoglycemic Agents Phase 4,Phase 3,Phase 2
172 Antibiotics, Antitubercular Phase 4,Phase 2,Phase 3,Not Applicable
173 Pharmaceutical Solutions Phase 4,Phase 2,Not Applicable
174 Expectorants Phase 4
175 Anticonvulsants Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
176 Antidotes Phase 4
177 Incretins Phase 4,Phase 2
178 Insulin, Globin Zinc Phase 4,Phase 1,Phase 2,Not Applicable
179 Antifungal Agents Phase 4,Not Applicable
180 Islet Amyloid Polypeptide Phase 4
181 Anti-Obesity Agents Phase 4,Phase 1,Not Applicable
182 Anti-Infective Agents, Local Phase 4
183 Liver Extracts Phase 4
184 Antitubercular Agents Phase 4,Phase 2,Phase 3,Not Applicable
185 Atomoxetine Hydrochloride Phase 4
186 Antiviral Agents Phase 4,Phase 3,Phase 2,Phase 1
187 Appetite Depressants Phase 4
188 Antineoplastic Agents, Hormonal Phase 4,Phase 2
189 Prednisolone acetate Phase 4
190 glucocorticoids Phase 4
191 Methylprednisolone acetate Phase 4
192 Methylprednisolone Hemisuccinate Phase 4
193 Epinephryl borate Phase 4
194 Prednisolone hemisuccinate Phase 4